We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+18.78%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.66B
AUM Growth
+$275M
Cap. Flow
+$68.7M
Cap. Flow %
4.14%
Top 10 Hldgs %
23.67%
Holding
233
New
36
Increased
109
Reduced
61
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 32.93%
2 Healthcare 19.82%
3 Industrials 15.24%
4 Consumer Discretionary 9.82%
5 Consumer Staples 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWST icon
101
Casella Waste Systems
CWST
$5.69B
$5.19M 0.31%
+202,549
New +$5M
MINI
102
DELISTED
Mobile Mini Inc
MINI
$5.19M 0.31%
110,568
-7,525
-6% -$340K
RDWR icon
103
Radware
RDWR
$1.19B
$5.14M 0.31%
203,366
+17,615
+9% +$410K
NTNX icon
104
Nutanix
NTNX
$16.9B
$5M 0.3%
96,988
-15,317
-14% -$842K
MGNX icon
105
MacroGenics
MGNX
$257M
$4.96M 0.3%
239,991
+20,727
+9% +$467K
PRFT
106
DELISTED
Perficient Inc
PRFT
$4.75M 0.29%
180,209
+3,127
+2% +$78.4K
CEVA icon
107
CEVA Inc
CEVA
$1.08B
$4.6M 0.28%
152,385
+35,766
+31% +$1.21M
QTS
108
DELISTED
QTS REALTY TRUST, INC.
QTS
$4.43M 0.27%
112,108
+67,526
+151% +$2.49M
DXCM icon
109
DexCom
DXCM
$32B
$4.39M 0.26%
184,796
+62,208
+51% +$1.32M
TCMD icon
110
Tactile Systems Technology
TCMD
$665M
$4.34M 0.26%
83,420
-25,076
-23% -$1.09M
ESPR
111
DELISTED
Esperion Therapeutics
ESPR
$4.21M 0.25%
+107,350
New +$5.42M
IMUX icon
112
Immunic
IMUX
$195M
$4.16M 0.25%
1,519
+128
+9% +$296K
WNS
113
DELISTED
WNS Holdings
WNS
$4.04M 0.24%
77,409
-2,823
-4% -$139K
CAI
114
DELISTED
CAI International, Inc.
CAI
$3.84M 0.23%
165,260
+17,855
+12% +$415K
NVEE
115
DELISTED
NV5 Global
NVEE
$3.79M 0.23%
+218,928
New +$3.41M
ADSW
116
DELISTED
Advanced Disposal Services Inc
ADSW
$3.77M 0.23%
152,230
+23,181
+18% +$539K
CTMX icon
117
CytomX Therapeutics
CTMX
$754M
$3.71M 0.22%
162,504
-88
-0.1% -$2.25K
LGND icon
118
Ligand Pharmaceuticals
LGND
$6.36B
$3.71M 0.22%
28,686
-25,067
-47% -$2.8M
JRVR icon
119
James River Group Holdings
JRVR
$217M
$3.65M 0.22%
92,761
+1,375
+2% +$51.9K
CARO
120
DELISTED
Carolina Financial Corp.
CARO
$3.57M 0.22%
83,154
+14,348
+21% +$596K
ECPG icon
121
Encore Capital Group
ECPG
$2.13B
$3.56M 0.21%
97,314
+18,262
+23% +$768K
CYBR
122
DELISTED
CyberArk
CYBR
$3.44M 0.21%
54,621
-3,802
-7% -$222K
WST icon
123
West Pharmaceutical
WST
$24.9B
$3.4M 0.2%
34,200
KIN
124
DELISTED
Kindred Biosciences, Inc.
KIN
$3.4M 0.2%
318,741
+153,479
+93% +$1.5M
PTC icon
125
PTC
PTC
$16B
$3.37M 0.2%
35,940
-2,203
-6% -$190K

Similar funds

Granahan Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Granahan Investment Management held 233 positions worth $1.66B, up 20% from $1.38B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Granahan Investment Management deployed $68.7M of net new capital in Q2 2018, opening 36 new positions and adding to 109 existing holdings. Its largest new stake was Globant: 437,078 shares worth $24.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Teladoc Health, an estimated $10.8M trimmed.

  • Granahan Investment Management's largest Q2 2018 buy was Globant: 437,078 shares worth $24.8M.
  • Granahan Investment Management added most to WW International in Q2 2018, an estimated $23.8M increase.
  • Granahan Investment Management's biggest Q2 2018 reduction was Teladoc Health, cutting an estimated $10.8M.
  • Granahan Investment Management fully exited MINDBODY, Inc. Class A Common Stock in Q2 2018, selling an estimated $9.71M.
  • Granahan Investment Management's ten largest holdings make up 24% of its $1.66B portfolio in Q2 2018.
  • Granahan Investment Management opened 36 new positions and closed 26 in Q2 2018.
  • Granahan Investment Management's portfolio value rose 20% quarter-over-quarter to $1.66B.

Based on Granahan Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.